Targeting BET Proteins Inhibited the Growth of Non-Small Cell Lung Carcinoma through Downregulation of Met Expression

Investigators found that JQ1, a bromodomain and extra terminal domain (BET) inhibitor, suppressed NSCLC cell growth, reduced the Met expression, and contributed to inactivation of PI3K/Akt and MAPK/ERK pathways.